455 results
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma - Recurrence-free Survival in the
Stage III or IV Melanoma ... Population #EBM #Honc ... Nivolumab #Ipilimumab #Melanoma ... #NEJM
Melanoma of the Foot - The physical examination revealed a well-defined, fleshy, reddish plaque measuring 2
Melanoma of the ... A melanoma with ... Derm #Podiatry #Honc ... AmelanoticMelanoma #Amelanotic #Melanoma ... #Foot #NEJM
Upper endoscopy revealed a pigmented mass in the duodenal bulb (Panel A) and two additional masses
Clinical #GI #Derm #Honc ... #Melanoma #Duodenum ... EGD #Metastatic #NEJM
Types of Melanoma
Superficial Spreading
 • Most common form
 • Often develops in previously benign mole
 •
Types of Melanoma ... • 70% of all melanomas ... 10-15% of all melanomas ... common type of melanoma ... #Melanoma #Types
Early Events in Acute GVHD #Pathophys #Honc #GVHD #GraftVersusHostDisease #NEJM
GVHD #Pathophys #Honc ... GraftVersusHostDisease #NEJM
Possible Mechanisms Underlying Immune-Related Adverse Events #Pathophys #Honc #ImmuneRelatedAdverseEvents #Immunotherapy #NEJM
Events #Pathophys #Honc ... Immunotherapy #NEJM
Acral Lentiginous Melanoma (involving nail)

While acral lentinginous melenoma is often seen anywhere on the palms, soles,
Acral Lentiginous Melanoma ... acral lentinginous melenoma ... clue that this is melanoma ... #Lentiginous #Melanoma
Biologic Events Leading to Chronic GVHD #Pathophys #Honc #Pharm #GVHD #GraftVersusHostDisease #Therapeutic #Pathways #NEJM
GVHD #Pathophys #Honc ... Therapeutic #Pathways #NEJM
The Pathway of Heme Synthesis, Showing Pathway Intermediates and End-Product Regulation by Heme #Pathophys #Honc #Heme
Heme #Pathophys #Honc ... Synthesis #Porphyria #NEJM
Role of G6PD in Protection against Oxidative Damage #Pathophys #Peds #Genetics #Honc #Favism #g6pd #NEJM
Peds #Genetics #Honc ... #Favism #g6pd #NEJM